Description
Recombinant human erythropoietins (rHuEPO) are erythropoiesis-stimulating agents (ESA) used in the treatment of anemia resulting from chronic kidney disease, treatments for cancer or HIV infection. They are also used perioperatively in some surgical patients.
Recombinant Human Erythropoietin Alfa is used in the treatment of anemia due to chronic kidney disease and anemia due to chemotherapy.